Maki Tanioka

6PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNanotoxicology, health and safetyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 12, 2025
Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer.

Takuya Nishina, Maki Tanioka, Kenji Takada

|Jul 29, 2025
Definitions of, Advances in, and Treatment Strategies for Breast Cancer Oligometastasis.

Tadahiko Shien, Shogo Nakamoto, Yuki Fujiwara

|Oct 16, 2024
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness.

Tomoka Mamori, Maki Tanioka, Kenji Takada

|Oct 17, 2022
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.

Shu Yazaki, Yuki Kojima, Hiroshi Yoshida

Pageof 1